Bayview Pharmacy's Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel is a specialized formulation designed for application into the urethra. It is dispensed in syringes for precise and controlled administration, delivering medication or lubrication for targeted treatment of urethral conditions or facilitating certain medical procedures. This formulation ensures accurate placement and optimal efficacy.

This formulation is used to treat a variety of urethral conditions, including erectile dysfunction, urinary incontinence, and urethral strictures. It can also be used to facilitate certain medical procedures, such as urethral dilation and catheterization. The combination of active ingredients in this formulation helps to relax the urethral muscles, allowing for improved blood flow and increased lubrication.

This formulation is easy to use and provides accurate and controlled administration. It is an effective treatment option for patients with urethral conditions, and can be used to facilitate certain medical procedures. If you have any questions about this formulation, please reach out to us at Bayview Pharmacy.

Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel is a gel-like formulation specifically designed for application into the urethra, dispensed in syringes for precise and controlled administration, delivering medication or lubrication for targeted treatment of urethral conditions or facilitating certain medical procedures, ensuring accurate placement and optimal efficacy. This formulation is indicated for the treatment of erectile dysfunction, Peyronie's disease, priapism, post-radical prostatectomy syndrome, and urethral stricture.

The combination of alprostadil, papaverine, and phentolamine in this formulation is thought to act synergistically to relax the smooth muscle of the corpus cavernosum, allowing for increased blood flow and improved erectile function. Alprostadil is a prostaglandin E1 analog that acts directly on the smooth muscle of the corpus cavernosum, while papaverine and phentolamine are non-selective phosphodiesterase inhibitors that act to increase the levels of cyclic guanosine monophosphate (cGMP) and nitric oxide (NO) in the corpus cavernosum.

It is important to note that this formulation should not be used in patients with known hypersensitivity to any of the components of the formulation. Additionally, caution should be used in patients with a history of cardiovascular disease, as the combination of alprostadil, papaverine, and phentolamine may increase the risk of cardiovascular events. Patients should be monitored for signs and symptoms of hypotension, tachycardia, and arrhythmias.

If you have any questions about this formulation or its use in the treatment of erectile dysfunction, Peyronie's disease, priapism, post-radical prostatectomy syndrome, or urethral stricture, please reach out to us.

Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel is a gel-like formulation specifically designed for application into the urethra, dispensed in syringes for precise and controlled administration. This formulation is used to treat a variety of urethral conditions, including erectile dysfunction, Peyronie's disease, priapism, post-radical prostatectomy syndrome, and urethral stricture.

The gel is applied directly into the urethra, where it delivers medication or lubrication for targeted treatment. This ensures accurate placement and optimal efficacy. The gel is dispensed in syringes for precise and controlled administration, allowing for accurate dosing and improved patient outcomes.

Patients should follow their doctor's instructions for using the gel. It is important to use the gel as directed and to not exceed the recommended dosage. Patients should also be aware of any potential side effects, such as burning, itching, or irritation.

Prescribers should consider the patient's medical history and any other medications they are taking before prescribing Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel. It is important to monitor the patient's response to the medication and adjust the dosage as needed.

If you have any questions about Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel, please reach out to us at Bayview Pharmacy. We are a knowledgeable team of compounding pharmacists and are here to help.

Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel is a gel-like formulation specifically designed for application into the urethra, dispensed in syringes for precise and controlled administration, delivering medication or lubrication for targeted treatment of urethral conditions or facilitating certain medical procedures, ensuring accurate placement and optimal efficacy. This formulation can also be used for other purposes, such as:

• To reduce the risk of urinary tract infections (UTIs) in patients with recurrent UTIs. This formulation can be used to coat the urethra and provide a protective barrier against bacteria, reducing the risk of infection.

• To reduce the risk of sexually transmitted infections (STIs) in patients with recurrent STIs. This formulation can be used to coat the urethra and provide a protective barrier against bacteria, reducing the risk of infection.

• To reduce the risk of post-operative infection in patients undergoing urological procedures. This formulation can be used to coat the urethra and provide a protective barrier against bacteria, reducing the risk of infection.

• To reduce the risk of post-operative pain in patients undergoing urological procedures. This formulation can be used to coat the urethra and provide a lubricating effect, reducing the risk of pain.

• To reduce the risk of post-operative bleeding in patients undergoing urological procedures. This formulation can be used to coat the urethra and provide a protective barrier against bleeding, reducing the risk of bleeding.

If you have any questions about the other uses of Alprostadil 250 mcg/Papaverine 7.5 mg/Phentolamine 1 mg/ml Urethral Gel, please reach out to us.